Metastatic renal-cell carcinoma developing in two recipients of renal grafts derived from the same donor.
Kooistra
M P
MP
Department of Nephrology, University Hospital Utrecht, The Netherlands.
Vos
P F
PF
de Graaf
P W
PW
Gmelig-Meyling
F H
FH
de Graeff
A
A
Lock
T M
TM
de Gast
G C
GC
Vroom
T M
TM
Hené
R J
RJ
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000209:etiology* / Q000556:secondary / Q000628:therapy; D005260:Female; D006680:HLA Antigens; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D014019:Tissue Donors
D006680:HLA Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007376:Interleukin-2; D011994:Recombinant Proteins